Article

Accelerating Medicines Partnership: Parkinson’s Disease. Genetic Resource

2020-11-20

Abstract excerpt

<h4>Background</h4> Whole-genome sequencing (WGS) data is available from several large studies across a variety of diseases and traits. However, massive storage and computation resources are required to use these data, and, to achieve the sufficient power for discoveries, harmonization of multiple cohorts is critical. <h4>Objectives</h4> The Accelerating Medicines Partnership Parkinson’s Disease (AMP PD) program h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56a17f46-5753-5052-87b5-82af16e86d62
DOI: 10.1101/2020.11.19.20235192

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Accelerating Medicines Partnership: Parkinson’s Disease. Genetic ResourceDOI 10.1101/2020.11.19.20235192Read

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.Semantic proximity Read

The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwide.Semantic proximity Read

Global Parkinson’s Genetics Program (GP2) Monogenic Network Protocol: Elucidating causative gene variants in hereditary Parkinson’s diseaseSemantic proximity Read

PD GENEration: An International Parkinson’s Disease Genetic Research StudySemantic proximity Read

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Semantic proximity Read

Tackling a disease on a global scale, the Global Parkinson’s Genetics Program, GP2: A new generation of opportunitiesSemantic proximity Read

Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Semantic proximity Read

The Global Parkinson’s Disease Genetics (GP2) Genome BrowserSemantic proximity Read

RETRACTED: A systematic genomic screen of 755 early-onset Parkinson’s patients from the 100,000 Genomes Project increases diagnostic yield and directs clinical pathwaysSemantic proximity Read

Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskSemantic proximity Read

NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsSemantic proximity Read

Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2Semantic proximity Read